Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition
Goudar, Ranjit K, Shi, Qing, Hjelmeland, Mark D, Keir, Stephen T, McLendon, Roger E, Wikstrand, Carol J, Reese, Elizabeth D, Conrad, Charles A, Traxler, Peter, Lane, Heidi A, Reardon, David A, Cavenee, Webster K, Wang, Xiao-Fan, Bigner, Darell D, Friedman, Henry S, Rich, Jeremy N
Published in Molecular cancer therapeutics (01.01.2005)
Published in Molecular cancer therapeutics (01.01.2005)
Get full text
Journal Article
SB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility
Hjelmeland, Mark D, Hjelmeland, Anita B, Sathornsumetee, Sith, Reese, Elizabeth D, Herbstreith, Michael H, Laping, Nicholas J, Friedman, Henry S, Bigner, Darell D, Wang, Xiao-Fan, Rich, Jeremy N
Published in Molecular cancer therapeutics (01.06.2004)
Published in Molecular cancer therapeutics (01.06.2004)
Get full text
Journal Article
The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion
Hjelmeland, Anita B, Lattimore, Kathryn P, Fee, Brian E, Shi, Qing, Wickman, Sarah, Keir, Stephen T, Hjelmeland, Mark D, Batt, David, Bigner, Darell D, Friedman, Henry S, Rich, Jeremy N
Published in Molecular cancer therapeutics (01.09.2007)
Published in Molecular cancer therapeutics (01.09.2007)
Get full text
Journal Article
Loss of phosphatase and tensin homologue increases transforming growth factor β-mediated invasion with enhanced SMAD3 transcriptional activity
HJELMELAND, Anita B, HJELMELAND, Mark D, QING SHI, HART, Janet L, BIGNER, Darell D, WANG, Xiao-Fan, KONTOS, Christopher D, RICH, Jeremy N
Published in Cancer research (Chicago, Ill.) (15.12.2005)
Published in Cancer research (Chicago, Ill.) (15.12.2005)
Get full text
Journal Article